Point of Care Diagnostics Market Size, Share, Trends by 2029
The point of care diagnostics market is projected to grow during the forecast
period due to the increasing incidences of infectious and chronic diseases. Fortune Business Insights™ publishes
this information in a report titled, "Point
of Care Diagnostics Market, 2022-2029".
As per the report, the point of care
diagnostics market size was valued at USD 46.65 billion in 2021. The market size is expected to rise
from USD 36.37 billion in 2022 to
USD 51.94 billion by 2029 at a CAGR of 5.2% during the projected period.
Click here to get
the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/industry-reports/point-of-care-diagnostics-market-101072
Increasing Manufacturing Of Test Kits To Bolster Market
Growth
The outbreak of COVID-19 pandemic affected various
industries in terms of revenue generation and production. However, the
healthcare sector has witnessed a positive impact of this pandemic. The point
of care diagnostics had high demand in the market due to increasing cases of
COVID-19 and rising demand for frequent tests. During the pandemic, key market
players have launched new products to meet customer demands. These factors have
bolstered the market growth during the pandemic period.
List of Key
Players Profiled in the Point of Care Diagnostics Market Report
- F. Hoffmann-La Roche Ltd (Basel,
Switzerland)
- Thermo Fisher Scientific Inc.
(Massachusetts, U.S.)
- Abbott Laboratories (Illinois, U.S.)
- Quest Diagnostics Incorporated (New
Jersey, U.S.)
- BD (Franklin Lakes, U.S.)
- bioMérieux SA (Marcy l'Etoile, France)
- Cardinal Health, Inc. (Ohio, U.S.)
- Mesa Biotech (California, U.S.)
- Cepheid (California, U.S.)
- Trinity Biotech (Bray, Ireland)
- Quidel Corporation (San Diego, U.S.)
- Bio-Rad Laboratories Inc. (California,
U.S.)
Detailed Table of Content:
- Point of Care Diagnostics Market Insights
- Overview: Details on
Causative Agents Responsible for Infectious Diseases
- Prevalence of Key Disease
Indications– For Key Country/Region
- Technological
Advancements in the Point of Care Diagnostics
- New Product Launch
- Overview of Regulatory
Scenario
- Key Industry Developments
- Mergers, Acquisitions, and Partnerships
- Overview of COVID-19
Impact on POC Diagnostics Market
- Major Factors Driving the
Impact of COVID-19
- Reimbursement Changes in
Response to COVID-19 Impact
- Opportunities Offered by
the Impact of COVID-19
- Overview of Global IVD
Market, 2021
- Global Point of Care Diagnostics Market 2029
- Key Findings / Summary
- Market Analysis, Insights
and Forecast – By Product
- Blood Glucose Monitoring
- Infectious Diseases
- Cardiometabolic Diseases
- Pregnancy & Infertility Testing
- Hematology Testing
- Others
- Market Analysis, Insights
and Forecast – By Sample
- Blood
- Nasal and Oropharyngeal Swabs
- Urine
- Others
TOC Continued…
About Us:
Fortune Business Insights™ delivers
accurate data and innovative corporate analysis, helping organizations of all
sizes make appropriate decisions. We tailor novel solutions for our clients,
assisting them to address various challenges distinct to their businesses. Our
aim is to empower them with holistic market intelligence, providing a granular
overview of the market they are operating in.
Contact Us:
Fortune
Business Insights™ Pvt. Ltd.
Pune -
411045, Maharashtra, India.
Phone:
US :+1 424
253 0390
UK : +44
2071 939123
APAC : +91
744 740 1245
Comments
Post a Comment